Geron (GERN) Return on Sales Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Geron | 856,799.98 | 856,799.98 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212.00 |
| Dec 31, 2025 | 475.00 |
| Sep 30, 2025 | 182.00 |
| Jun 30, 2025 | 378.00 |
| Mar 31, 2025 | 310.00 |
| Dec 31, 2024 | 169.00 |
| Sep 30, 2024 | 113.00 |
| Jun 30, 2024 | 64.00 |
| Mar 31, 2024 | -4.00 |
| Dec 31, 2023 | 266.00 |
| Sep 30, 2023 | -237.00 |
| Jun 30, 2023 | -1,665.00 |
| Mar 31, 2023 | -1,795.00 |
| Dec 31, 2022 | 126.00 |
| Sep 30, 2022 | -95.00 |
| Jun 30, 2022 | -364.00 |
| Mar 31, 2022 | -231.00 |
| Dec 31, 2021 | 59.00 |
| Sep 30, 2021 | -244.00 |
| Jun 30, 2021 | -235.00 |
| Mar 31, 2021 | -200.00 |
| Dec 31, 2020 | -436.00 |
| Sep 30, 2020 | -183.00 |
| Jun 30, 2020 | -341.00 |
| Mar 31, 2020 | -293.00 |
| Dec 31, 2019 | -120.00 |
| Sep 30, 2019 | -53.00 |
| Jun 30, 2019 | -115.00 |
| Mar 31, 2019 | -160.00 |
| Dec 31, 2018 | 18.00 |
| Sep 30, 2018 | 9.00 |
| Jun 30, 2018 | 48.00 |
| Mar 31, 2018 | -7.00 |
| Dec 31, 2017 | -16.00 |
| Sep 30, 2017 | -17.00 |
| Jun 30, 2017 | 104.00 |
| Mar 31, 2017 | 2.00 |
| Dec 31, 2016 | 30.00 |
| Sep 30, 2016 | 89.00 |
| Jun 30, 2016 | 5.00 |
| Mar 31, 2016 | 4.00 |
| Dec 31, 2015 | -104.00 |
| Sep 30, 2015 | 89.00 |
| Jun 30, 2015 | -21.00 |